Dr. Abraham Chachoua specializes in the treatment of thoracic malignancies. Originally trained in Melbourne, Australia, he came to NYU to complete a research fellowship in medical oncology and was the recipient of an American Cancer Society career development award to evaluate the role of immune modulation in the treatment of solid tumors.
He has been involved in a number of clinical trials for the treatment of non small cell lung cancer.
Dr. Chachoua has a particular interest in the study of novel targeted therapies, how to use them earlier in the course of the illness and how to combine them with conventional chemotherapy for the treatment of advanced thoracic cancers. Among other interests he also attempts to use unique approaches for the integration of multimodality approaches for the treatment of locally advanced lung cancer.